Provided by Tiger Trade Technology Pte. Ltd.

Agree

67.38
+0.26000.39%
Volume:365.06K
Turnover:24.50M
Market Cap:8.38B
PE:36.39
High:67.48
Open:67.38
Low:66.85
Close:67.12
52wk High:82.08
52wk Low:66.50
Shares:124.38M
Float Shares:122.18M
Volume Ratio:0.46
T/O Rate:0.30%
Dividend:3.14
Dividend Rate:4.66%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.32
PE(LYR):38.07

Loading ...

Impact Therapeutics Nominates Preclinical Candidate for GI Cancers

MT Newswires Live
·
Jul 27

IMPACT Therapeutics Unveils First Dual-Payload ADC Preclinical Candidate IMP3201

TIPRANKS
·
Jul 27

Does Agree Realty's Higher 2026 Dividend Payout Reveal a Deeper Capital Allocation Shift for ADC?

Simply Wall St.
·
Jul 26

BIOKIN's T-Bren (HER2 ADC) Trial Enrolls First Subject in Phase III Study

Stock News
·
Jul 26

West Java's Street Crime Bounty Plan: Does the Minister Agree?

Tempo
·
Jul 24

Press Release: Samsung Epis Holdings Reports Second Quarter and Half-year 2026 Financial Results

Dow Jones
·
Jul 24

Sichuan Biokin Pharmaceutical's ADC Enters Phase Three Trial for Biliary Tract Cancer

MT Newswires Live
·
Jul 24

Earning Preview: Agree Realty revenue is expected to increase by 18.08%, and institutional views are bullish

Earnings Agent
·
Jul 24

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

GlobeNewswire
·
Jul 24

Agree Realty (ADC) Stock Looks Fully Valued With Strong Returns But Rich Earnings

Simply Wall St.
·
Jul 24

Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity

GlobeNewswire
·
Jul 22

Agree Realty is Maintained at Equal-weight by Barclays

Dow Jones
·
Jul 22

Agree Realty price target raised to $85 from $84 at Barclays

TIPRANKS
·
Jul 22

U.s. Research Roundup-danaher, Gm, Msci

Reuters
·
Jul 22

Lonza Lifts 2026 Margin Outlook as CDMO Strategy and ADC Investments Drive Strong Half-Year Results

TIPRANKS
·
Jul 22

Analysts Offer Insights on Real Estate Companies: Agree Realty (ADC) and AvalonBay (AVB)

TIPRANKS
·
Jul 21

ADC Therapeutics Halts LOTIS-10 Liver-Impairment Study: What It Means for Zynlonta and Investors

TIPRANKS
·
Jul 21

Biohaven to Unveil Clinical Data for BHV-1530 ADC Candidate at ESMO Congress

Deep News
·
Jul 20

Maxim upgrades Akari Therapeutics to Buy on AKTX-101 data, ADC M&A

TIPRANKS
·
Jul 20

Blackstone-Backed Private Equity Funds Agree to Invest in South Korea's Futronic

MT Newswires Live
·
Jul 20